Back
Molecular Partners AG Stock Predictions
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
MOLN
Molecular Partners AG
Last Price:
$4.09
Seasonality Move:
-25.38%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Molecular Partners AG Stock Forecast
-
Is Molecular Partners AG Stock Undervalued?The current Molecular Partners AG [MOLN] share price is $4.33. The Score for MOLN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
MOLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Molecular Partners AG Stock Go Up Next Year?
Data Unavailable
Molecular Partners AG Stock Rating
Data Unavailable
Molecular Partners AG Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Switzerland
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
molecularpartners.com
52-Week Data
52-Week High:
12.70
52-Week Low:
3.32
Prediction Charts
Market Cap:
159.7M
Price in USD:
4.33
Volume:
581
Beta:
1.08
Technical Analysis
SMA50:
5.04
SMA100:
5.35
SMA200:
5.61
52-Wk Change:
12.03%
Stock Predictions
-
Is Molecular Partners AG stock public?Yes, Molecular Partners AG is a publicly traded company.
-
What is the Molecular Partners AG stock quote today?The Molecular Partners AG stock price is 4.33 USD today.
-
How to buy Molecular Partners AG stock online?You can buy Molecular Partners AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-21 | 4.80 | 4.68 | 5.04 | 4.68 |
| Feb-25 | 4.90 | 4.90 | 4.90 | 4.90 |
| Feb-26 | 4.87 | 4.87 | 4.87 | 4.87 |
| Feb-27 | 4.82 | 4.85 | 4.85 | 4.82 |
| Feb-28 | 4.60 | 5.03 | 5.05 | 4.60 |
| Mar-3 | 5.03 | 5.03 | 5.03 | 5.03 |
| Mar-4 | 4.68 | 4.68 | 5.00 | 4.67 |
| Mar-5 | 4.61 | 4.90 | 4.98 | 4.61 |
| Mar-6 | 4.65 | 5.01 | 5.01 | 4.65 |
| Mar-7 | 4.54 | 5.01 | 5.10 | 4.48 |
| Mar-11 | 4.49 | 4.50 | 4.70 | 4.32 |
| Mar-12 | 4.31 | 4.42 | 4.63 | 4.31 |
| Mar-13 | 4.40 | 4.39 | 4.40 | 4.39 |
| Mar-14 | 4.34 | 4.33 | 4.35 | 4.33 |
Molecular Partners AG Earnings
Data Unavailable
Molecular Partners AG Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.41 per share.
* Molecular Partners AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.